Premium
Female Mice are Resistant to Fabp1 Gene Ablation‐Induced Alterations in Brain Endocannabinoid Levels
Author(s) -
Martin Gregory G.,
Chung Sarah,
Landrock Danilo,
Landrock Kerstin K.,
Dangott Lawrence J.,
Peng Xiaoxue,
Kaczocha Martin,
Murphy Eric J.,
Kier Ann B.,
Schroeder Friedhelm
Publication year - 2016
Publication title -
lipids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.601
H-Index - 120
eISSN - 1558-9307
pISSN - 0024-4201
DOI - 10.1007/s11745-016-4175-4
Subject(s) - endocannabinoid system , biology , fatty acid binding protein , medicine , endocrinology , arachidonic acid , receptor , gene , biochemistry , enzyme
Although liver fatty acid binding protein (FABP1, L‐FABP) is not detectable in the brain, Fabp1 gene ablation (LKO) markedly increases endocannabinoids (EC) in brains of male mice. Since the brain EC system of females differs significantly from that of males, it was important to determine if LKO differently impacted the brain EC system. LKO did not alter brain levels of arachidonic acid (ARA)‐containing EC, i.e. arachidonoylethanolamide (AEA) and 2‐arachidonoylglycerol (2‐AG), but decreased non‐ARA‐containing N ‐acylethanolamides (OEA, PEA) and 2‐oleoylglycerol (2‐OG) that potentiate the actions of AEA and 2‐AG. These changes in brain potentiating EC levels were not associated with: (1) a net decrease in levels of brain membrane proteins associated with fatty acid uptake and EC synthesis; (2) a net increase in brain protein levels of cytosolic EC chaperones and enzymes in EC degradation; or (3) increased brain protein levels of EC receptors (CB1, TRVP1). Instead, the reduced or opposite responsiveness of female brain EC levels to loss of FABP1 (LKO) correlated with intrinsically lower FABP1 level in livers of WT females than males. These data show that female mouse brain endocannabinoid levels were unchanged (AEA, 2‐AG) or decreased (OEA, PEA, 2‐OG) by complete loss of FABP1 (LKO).